Dapagliflozin, an inhibitor of sodium-glucose cotransporter 2 (SGLT2), is a novel class of oral hypoglycemic drugs that promote glucose excretion in the kidney. Studies have shown that dapagliflozin h
Eight-week-old db/db mice were intraperitoneally injected with vehicle or tacrolimus three times a week for a total of four weeks. RNA was extracted from the liver and sequenced. Among them, the files